IE
NUVB icon

Israel Englander’s Nuvation Bio NUVB Stock Holding History

Israel Englander’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.12M Sell
372,858
-749,322
-67% -$3.66M ﹤0.01% 3770
2026
Q1 		$4.81M Buy
1,122,180
+410,636
+58% +$2.29M ﹤0.01% 2989
2025
Q4 		$6.38M Sell
711,544
-4,140,674
-85% -$25.6M ﹤0.01% 2744
2025
Q3 		$18M Sell
4,852,218
-527,967
-10% -$1.44M 0.01% 1782
2025
Q2 		$10.5M Buy
5,380,185
+1,606,182
+43% +$3.35M 0.01% 2204
2025
Q1 		$6.64M Buy
3,774,003
+1,298,131
+52% +$2.95M ﹤0.01% 2587
2024
Q4 		$6.59M Buy
2,475,872
+1,120,874
+83% +$2.89M ﹤0.01% 2575
2024
Q3 		$3.1M Buy
1,354,998
+932,686
+221% +$2.84M ﹤0.01% 3267
2024
Q2 		$1.23M Sell
422,312
-481,978
-53% -$1.47M ﹤0.01% 3952
2024
Q1 		$3.29M Sell
904,290
-2,190,379
-71% -$4.21M ﹤0.01% 3285
2023
Q4 		$4.67M Buy
3,094,669
+1,715,172
+124% +$2.21M ﹤0.01% 2849
2023
Q3 		$1.85M Buy
1,379,497
+1,223,936
+787% +$2.04M ﹤0.01% 3626
2023
Q2 		$280K Sell
155,561
-332,728
-68% -$566K ﹤0.01% 4935
2023
Q1 		$811K Sell
488,289
-55,289
-10% -$112K ﹤0.01% 4282
2022
Q4 		$1.04M Buy
543,578
+377,347
+227% +$763K ﹤0.01% 4116
2022
Q3 		$372K Sell
166,231
-306,542
-65% -$875K ﹤0.01% 5209
2022
Q2 		$1.53M Buy
+472,773
New +$2.06M ﹤0.01% 3972
2021
Q4 		– Sell
-373,471
Closed -$3.71M – 7191
2021
Q3 		$3.71M Buy
+373,471
New +$3.39M ﹤0.01% 3221
2021
Q2 		– Sell
-1,382,018
Closed -$14.4M – 6912
2021
Q1 		$14.4M Buy
1,382,018
+1,085,824
+367% +$12.1M 0.01% 1409
2020
Q4 		$3.46M Buy
296,194
+160,447
+118% +$1.67M ﹤0.01% 2792
2020
Q3 		$1.52K Buy
+135,747
New +$1.47M ﹤0.01% 2806

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Israel Englander's NUVB Position: Q2 2026 in Review

Israel Englander reduced its Nuvation Bio (NUVB) stake by 67% in Q2 2026, selling an estimated $3.66M and leaving 372,858 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3770.

Israel Englander first reported a position in NUVB in Q3 2020 and has held it in 21 quarters since. The position peaked at $18M in Q3 2025. 242 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Israel Englander held 372,858 shares of Nuvation Bio worth $2.12M as of Q2 2026.
  • Israel Englander sold 749,322 Nuvation Bio shares in Q2 2026, an estimated $3.66M.
  • Nuvation Bio made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3770 holding.
  • Israel Englander first reported a position in Nuvation Bio in Q3 2020 and has held it in 21 quarters since.
  • Israel Englander's Nuvation Bio position peaked at $18M in Q3 2025.
  • 242 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.